Approval · Notice of Compliance 5916 · 2004
PEGETRON: Notice of Compliance 5916
Issued November 26, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5916
- Date
- November 26, 2004
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing area
- Therapeutic class
- Biological response modifier plus antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEGETRON | Not yet assigned | — |
Medicinal ingredients
- PEGINTERFERON ALFA-2B 50 MCG per 0.5ML
- RIBAVIRIN 200 MG per CAP
- PEGINTERFERON ALFA-2B 80 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 100 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 120 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 150 MCG per 0.5ML